Download (2337Kb) - Universidad Autónoma de Nuevo León

49. Kuttner, B. J., and R. J. Siegle. 1986. Treatment of chromomycosis with a CO2
laser. J Dermatol Surg Oncol 12:965-968.
50. Kwon-Chung, K. J. a. J. E. B. (ed.). 1992. Chromoblastomycosis, Philadelphia,
USA.
51. Lavalle, P. 1975. Chromomycosis. Clinical Tropical Dermatology London:
Blackwell Scientific Publications; 36-41.
52. Mazo Favero, V., M. Da Gloria de Souza, K. S. Ferreira, S. G. Marques, A. G.
Goncalves, D. Vagner de Castro Lima Santos, M. Pedroso e Silva Cde, and S.
R. Almeida. 2005. Cytokines and lymphocyte proliferation in patients with
different clinical forms of chromoblastomycosis. Microbes Infect 7:708-713.
53. McGinnis, M. R. 1983. Chromoblastomycosis and phaeohyphomycosis: new
concepts, diagnosis, and mycology. J Am Acad Dermatol 8:1-16.
54. McGinnis, M. R., and L. Pasarell. 1998. In vitro evaluation of terbinafine and
itraconazole against dematiaceous fungi. Med Mycol 36:243-246.
55. McGinnis, M. R., and L. Pasarell. 1998. In vitro testing of susceptibilities of
filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with
consideration of phylogenetic implications. J Clin Microbiol 36:2353-2355.
56. Meyer, R. D. 1992. Current role of therapy with amphotericin B. Clin Infect Dis 14
Suppl 1:S154-160.
57. Najafzadeh, M. J., A. Rezusta, M. I. Cameo, M. L. Zubiri, M. C. Yus, H.
Badali, M. J. Revillo, and G. S. De Hoog. 2010. Successful treatment of
chromoblastomycosis of 36 years duration caused by Fonsecaea monophora. Med.
Mycol. 48:390-393.
68